A citation-based method for searching scientific literature

Laween Uthman, Antonius Baartscheer, Boris Bleijlevens, Cees A Schumacher, Jan W T Fiolet, Anneke Koeman, Milena Jancev, Markus W Hollmann, Nina C Weber, Ruben Coronel, Coert J Zuurbier. Diabetologia 2018
Times Cited: 190



Subodh Verma, John J V McMurray. Diabetologia 2018
Times Cited: 300




List of shared articles



Times cited




Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.
Volker Vallon, Subodh Verma. Annu Rev Physiol 2021
12

Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue.
Alessandro De Stefano, Manfredi Tesauro, Nicola Di Daniele, Giuseppina Vizioli, Francesca Schinzari, Carmine Cardillo. Hypertension 2021
1

Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review.
Vincenzo Mollace, Giuseppe M C Rosano, Stefan D Anker, Andrew J S Coats, Petar Seferovic, Rocco Mollace, Annamaria Tavernese, Micaela Gliozzi, Vincenzo Musolino, Cristina Carresi,[...]. Nutrients 2021
3

Sodium-glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia-reperfusion injury: a meta-analysis.
Alex Ali Sayour, Csilla Celeng, Attila Oláh, Mihály Ruppert, Béla Merkely, Tamás Radovits. Diabetologia 2021
3

Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study.
Ernesto Martín, José López-Aguilera, Rafael González-Manzanares, Manuel Anguita, Guillermo Gutiérrez, Aurora Luque, Nick Paredes, Jesús Oneto, Jorge Perea, Juan Carlos Castillo. J Clin Med 2021
0

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin.
Koenraad Philippaert, Subha Kalyaanamoorthy, Mohammad Fatehi, Wentong Long, Shubham Soni, Nikole J Byrne, Amy Barr, Jyoti Singh, Jordan Wong, Taylor Palechuk,[...]. Circulation 2021
8

The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence.
Manasvi Gupta, Shiavax Rao, Gaurav Manek, Gregg C Fonarow, Raktim K Ghosh. Ther Clin Risk Manag 2021
0

SGLT2 Inhibitors and Their Mode of Action in Heart Failure-Has the Mystery Been Unravelled?
Steffen Pabel, Nazha Hamdani, Mark Luedde, Samuel Sossalla. Curr Heart Fail Rep 2021
0

SGLT2 inhibitors in heart failure with reduced ejection fraction.
Uday Sankar Das, Aritra Paul, Suvro Banerjee. Egypt Heart J 2021
0



Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry.
Viveca Ritsinger, Thomas Nyström, Nawsad Saleh, Bo Lagerqvist, Anna Norhammar. Eur J Prev Cardiol 2020
4

Second revolution in cardiovascular prevention.
Chern-En Chiang, Kang-Ling Wang, Hao-Min Cheng, Shih-Hsien Sung, Tze-Fan Chao. J Chin Med Assoc 2020
1